AAOpt 2024: What to know about performing capsulotomy and vitreolysis procedures

News
Video

Nate Lighthizer, OD, FAAO, overviews a handful of YAG laser procedures in his AAOpt presentation.

Nate Lighthizer, OD, FAAO, recently presented on "YAG Lasers: Capsulotomy and Vitreolysis," at the American Academy of Optometry meeting. Lighthizer provides an overview of the two main laser procedures discussed in his presentation – YAG laser capsulotomy and YAG laser vitreolysis (laser floater removal). Lighthizer explains that YAG laser capsulotomy is the most common laser procedure performed by optometrists and ophthalmologists. It is used to clear a cloudy membrane that can develop after cataract surgery, significantly improving the patient's vision. He describes the procedure as quick, taking 1-5 minutes, and highly rewarding as patients are very satisfied with the results.

The other procedure covered is YAG laser vitreolysis, which is an in-office laser treatment for symptomatic floaters. Lighthizer notes this procedure is gaining popularity as it offers a middle ground between just observing floaters and undergoing a more invasive vitrectomy surgery. He outlines the ideal candidate as someone who has had the floater for at least 6 months, with symptoms matching the structural appearance of the floater. Lighthizer emphasizes the importance of successful co-management between optometrists and ophthalmologists for capsulotomy patients. This includes identifying appropriate candidates, educating patients, and closely monitoring post-operative recovery. He also encourages optometrists in the 12 states that currently allow laser procedures to consider offering these services, as the number of states is expected to grow.

Overall, Lighthizer's presentation aimed to increase awareness of these laser procedures and inspire optometrists to incorporate them into their scope of practice where permitted. He believes these treatments can significantly improve patients' vision and quality of life.

Recent Videos
Nora Lee Cothran, OD, FAAO, details a real-world study that found IOP-lowering benefits when switching patients with glaucoma to latanoprostene bunod treatment.
Mile Brujic, OD, FAAO; Nate Lighthizer, OD, FAAO; Brianna Rhue, OD, FAAO, FSLS; Ben Casella, OD; and Ben Gaddie, OD, FAAO shared their insights from the conference.
Dr. Stephanie Woo discusses the upcoming CRU Eye Symposium
Agatha Sleboda, OD; Arti Shah, OD, FAAO; and Kent J. Nozacki, OD provide the best tips that they give to their patients during natural disasters events in light of the recent Greater Los Angeles wildfires.
Optometrists local to the Los Angeles area overview their efforts to continue providing support to patients affected by January's wildfires.
Brianna Rhue, OD, FAAO, FSLS, reviewed key takeaways from The Future of Myopia Management: Perspectives from Leading Experts talk from SECO 2025.
Dr. Nate Lighthizer shares key takeaways from the SECO Showcase on anterior segment technology and full laser certification course offered at SECO.
Dr. Ben Casella highlights the importance of SECO to the optometric community.
Dr. Mile Brujic discusses a case series on a novel gel for lacrimal occlusion.
© 2025 MJH Life Sciences

All rights reserved.